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Summary
Crosslinking of surface immunoglobulins (sIg) in B cells led to the accumulation of submembranal
phosphotyrosine, which was followed morphologically with the PY20 antiphosphotyrosine
monoclonal antibody. Phosphotyrosine was not detected before sIg crosslinking. After sIg
crosslinking, phosphotyrosine-containing proteins were redistributed from scattered small clusters
near the plasma membrane to ajuxtanuclear region, where immunofluorescent staining decreased
with time. Double immunofluorescent staining of individual cells showed accumulation of
phosphotyrosine beneath crosslinked sIg molecules at the cell surface. The sIg molecules were
subsequently internalized more rapidly than the phosphotyrosine-containing molecules were
redistributed. Genistein, a protein tyrosine kinase (PTK) inhibitor, blocked intracellular tyrosine
phosphorylations but not cell surface patching of crosslinked sIg. When polyacrylamide beads
coated with anti-Ig antibodies were added to the cells, intracellular tyrosine phosphorylation
occurred beneath the regions of contact with the beads. This study provides an independent
line of evidence confirming recent biochemical experiments that show that crosslinking of the
antigen receptor induces PTK activity in B cells, and that components of the newly described
sIg'complex are among the PTK substrates. The surprising finding that the bulk of the induced
phosphotyrosine remains associated with crosslinked s1g for many minutes suggests a role for
complex local protein interactions in phosphotyrosine-mediated signal transduction through the
antigen receptor of B cells.
Crosslinking of surface immunoglobulin (sIg),' the B cellantigen receptor, initiates a complex cellular response.
Upon crosslinking, most sIg becomes physically associated
with detergent insoluble cytoskeletal components (1, 2), fol-
lowed by patching, capping, and endocytosis (3) . Crosslinking
of sIg activates phospholipase C (PLC)-mediated hydrolysis
of phosphatidyl inositol to inositol triphosphate and diacyl-
glycerol, which lead, respectively, to increased free intracel-
lular Cat+ and activation of Cat+-regulated kinases, and to
protein kinase C (PKC) activation (4-6) . GTP-binding pro-
teins) appear to couple sIg receptors to inositol phospho-
lipid hydrolysis (7-10) . sIg associates noncovalently with one
isotype-specific 32-33-kD protein and two non-isotype-
specific proteins of34 and 37-38 kD (11, 12) . These proteins
may be involved in coupling sIg to GTP-binding proteins
(in a manner analogous to the T cell CD3 signal transducer
1 Abbreviations used in this paper. PKC, protein kinase C ; PLC,
phospholipase C PTK, protein tyrosine kinase ; PTPase, protein tyrosine
phosphatase; sIg, surface immunoglobulin(s) ; TRITC, tetramethyl
rhodamine isothiocyanate.
complex) by forming a sIg receptor complex, since sIg mole-
cules lack a cytoplasmic tail like that shared by receptors that
interact directly with GTP-binding proteins .
Crosslinking of sIg also leads to very rapid tyrosine phos-
phorylation by protein tyrosine kinases (PTKs) of several cy-
toplasmic and membrane proteins (13-15) . Although pro-
tein substrates are assumed to be modified functionally by
the phosphorylation of tyrosine residues, the identities and
functions of those substrates are not fully described. In addi-
tion, the membrane-associated protein tyrosine phosphatase
(PTPase) CD45 (16) regulates signal transduction in B cells .
Antibodies to CD45 inhibit an early phase in B cell activa-
tion initiated by anti-Ig antibodies and characterized by an
initial rise in intracellular Cal+ concentration (17), and
phosphatidyl inositol breakdown (18). Thus, protein phos-
phorylations and dephosphorylations on tyrosine are likely
to regulate signal transduction initiated by sIg crosslinking .
To study the role of protein tyrosine phosphorylation in
antigen receptor signal transduction in B cells, we have charac-
terized by immunofluorescence the appearance and subcel-
lular location, redistribution, and disappearance of tyrosine
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phosphorylated proteins in Bcells after crosslinking sIg. Tyro-
sine phosphorylated proteins accumulate directly under cross-
linked sIg, so it appears that the major substrates for the in-
duced PTK activity remain associated with crosslinked sIg.
Materials and Methods
Cells and Culture Conditions.
	
Akata cells (19) and Ramos cells
(20) were grown in RPMI 1640 supplemented with 10% heat-
inactivated FCS at 37°C in a humidified atmosphere of 5% CO2
in air. Peripheral blood B cells were isolated from a healthy adult
as described (21) . For sIg crosslinking, cells were suspended in fresh
medium at 106 cells/ml, and 50 Ftg/ml F(ab')2 fragments of Ig
class-specific goat anti-human IgG or IgM antibodies (Cappel
Laboratories, West Chester, PA) dialyzed against PBS were added
for indicated times at 37°C . Alternately, 50 ttg/ml rabbit
anti-human Ig Immunobeads (Bio-Rad Laboratories, Richmond,
CA) were used .
Immunofluorescence Procedures . Cells were washed with PBS,
spotted onto a glass slide, dried, and fixed and permeabilized with
methanol/acetone (1 :1) at -20°C for 10 min. Cells were stained
with a 1:100 dilution of PY20mAb (ICN ImmunoBiologicals, Costa
Mesa, CA) (22) specific for phosphobenzene derivatives such asphos-
photyrosine and phenylphosphate, washed, and incubated with
FITC-conjugated goat anti-mouse Ig antibodies (Cappel Labora-
tories) or with tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated donkey anti-mouse Ig antibodies (Jackson Immuno-
research, West Grove, PA). For double-label immunofluorescence,
FITC-conjugated F(ab')2 fragments of goat anti-human Ig anti-
bodies were used for stimulation of cells. After fixation, the slides
were stained with PY20 mAb and then with TRITC-conjugated
donkey anti-mouse Ig antibodies . Double-label immunofluorescence
was also used for staining of cells cultured with Immunobeads.
Cells were stained with PY20 mAb andthen with FITC-conjugated
donkey anti-rabbit Ig antibodies Qackson Immunoresearch) and
TRITC-conjugated donkey anti-mouse Ig antibodies. Stained slides
were mounted in 50% glycerol in PBS and viewed under a stan-
dard microscope equipped for phase contrast and fluorescence mi-
croscopy with a Planapo 63 x objective lens (Carl Zeiss, Inc., Thom-
wood, NY). The filter sets discriminated completely the fluorescence
from the two fluorochromes . At least 250 cells at each time point
were counted for classification . Photographs were taken on Kodak
Tri-X film .
OtherReagents. O-phospho-L-tyrosine, calcium ionophore A23-
187, dioctanoylglycerol, TRITC-conjugated wheat germ agglutinin,
TRITC-conjugated Con A, andDMSO were obtained from Sigma
Chemical Co., St . Louis, MO. Genistein was from ICN Immuno-
Biologicals . Sodium orthovanadate was from Fisher Scientific Co .,
Pittsburgh, PA.
Results
Detection of Tyrosine Phosphorylation by Immunofluorescent
Labeling. sIg molecules of Akata or Ramos cells were cross-
linked with F(ab')2 fragments of goat anti-human IgG or
IgM antibodies, respectively. The prominent phosphotyro-
sine labeling of both cells was observed as clusters (Fig . 1,
A and B) . Since PY20 mAb did not stain living, intact cells,
the immunofluorescent staining of phosphotyrosine was in-
tracellular, consistent with the known location of PTKs at
the inner surface of the plasma membrane or in the cytoplasm
(23) . The reaction of the PY20 antiphosphotyrosine mAb
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Figure 1 . Phosphotyrosine staining. Cells were incubated with F(ab')2
fragments of goat anti-human Ig antibodies, fixed with acetone/meth-
anol (1 :1), and stained with PY20 antiphosphotyrosine mAb followed by
FITC-conjugated goat anti-mouse Ig antibodies. Fluorescent patches were
observed in both Akata cells (A) and Ramos cells (B) 5 min after treat-
ment with anti-Ig antibodies. No staining was seen with PY20 mAbblocked
with phosphotyrosine (10 mM) (D, Akata cells) . Unactivated cells were
not stained (F, Akata cells) . Phase contrast micrographs of the fields of
D and F were shown in C and E, respectively (x900) .
was inhibited completely by phosphotyrosine (10 mM) (Fig.
1, C and D). No immunofluorescence was seen in unacti-
vated cells (Fig. 1, E and F) . When cells were treated with
the diacylglycerol analog, dioctanoylglycerol, an agonist for
PKC, and A23187, a calcium ionophore, no PY20-positive
cells were seen (data not shown) .
Redistribution ofPhosphotyrosine To study the induction
of protein tyrosine phosphorylation and how the proteins
were redistributed and dephosphorylated, Akata cells were
stained with PY20 mAb at various times after stimulation
with anti-Ig antibodies (Fig . 2) . Almost all cells were stained
with PY20 mAb at 2 min. Maximal induction of PY20-
positive cells was constant from 2 to 30 min and then the
percentage ofpositive cells decreased. The frequencies of three
types ofimmunofluorescent patterns were classified as a func-
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Figure 2 . Time course oftyrosine Phosphorylation . At indicated times
ofincubation with anti-Ig antibodies, Akata cells were labeled with PY20
mAb as described for Fig. 1 and classified by the illustrated criteria . Type
1, scattered dots without concentration ; Type 2, accumulation of dots in
a juxtanuclear region; Type 3, largepatch formation without juxtanuclear
accumulation. Cells of types 1, 2, and 3 are shown in Fig. 3 A, a, c, and
d, respectively.
tion of time (Fig. 2) . Type 1 cells had fine, punctate patches
widely distributed near the cell surfaces asjudged by focusing
through different layers of the cell (Fig . 3 A, a) . Type 2 cells
showed accumulation of PY20-labeled molecules in one or
more regions (Fig. 3 A, c), which werejuxtanuclear, asjudged
by double staining with TRITC-conjugated wheat germ ag-
glutinin, which reacted with glycoconjugates unique to the
Golgi apparatus (24) (Fig. 3 B) . In the first 30 min, type
1 cells decreased as the type 2 cells increased . The percentage
of type 2 cells peaked at 30 min and then declined . Type 3
cells had large patches near the cell surface and lacked ac-
cumulations in juxtanuclear regions (Fig. 3 A, d) . Their per-
centage remained constant during the entire time of obser-
vation .
Double Staining for sIg and Phosphotyrosine Molecules. To
test how sIg and tyrosine phosphorylated proteins were as-
sociated, double staining for sIg and phosphotyrosine mole-
cules was undertaken. Akata and Ramos cells were stimu-
lated with FITC-conjugated F(ab')2 fragments of goat
anti-human Ig antibodies, fixed, and stained with PY20 mAb
followed by TRITC-conjugated donkey anti-mouse Ig anti-
bodies (Fig . 3 A) . The locations of tyrosine phosphorylated
molecules and sIg molecules overlapped closely in the majority
of Akata cells (Fig. 3 A, a, b, c, and d) and Ramos cells (Fig.
3 A, f) . PY20-labeled dots appeared exactly with the cell
surface distribution of sIg. When the primary PY20 mAb
was omitted from the staining procedure, no TRITC fluores-
cence was detected (data not shown), indicating that the sec-
ondary anti-mouse Ig antibodies do not crossreact with human
B cell sIg nor with goat anti-human Ig antibodies . Further-
more, phosphotyrosine (10 mM) completely abolished staining
with PY20 mAb. Therefore, both antigens were actually rec-
ognized and the apparent colocalization could not be owing
to an artifact of the fluorescent antibody procedure. During
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microscopy, sharply focusing for one fluorochrome near the
top of the cell rendered the alternate label slightly out of focus,
presumably since extracellular anti-Ig antibodies were not ex-
actly in the same plane of focus as the intracellular phos-
photyrosine label .
Although sIg and PY20-positive dots were associated at
the cell surface, intracellular migration of PY20-stained dots
appeared to differ from that of sIg in some cells (Fig . 3 A,
e) . To test whether dephosphorylation during internalization
caused this difference, vanadate (1.0 mM), an inhibitor of
PTPase (25), was added . Vanadate inhibited fading of PY20
labeling : 89.7% ofcells were still positive for PY20 after 1 h
incubation with anti-Ig antibodies and vanadate. In addition,
after incubation with vanadate in both control and anti-Ig
cultures, a small number (<5%) of diffusely PY20-stained
cells appeared, presumably due to effective inhibition of PTPase
activity. This treatment did not alter the distributions of ei-
ther sIg or PY20-stained molecules up to 30 min . The redis-
tribution of both sIg and PY20 mAb-recognized molecules
was determined in individual cells as a function of time after
sIg stimulation (Fig. 4) . Cells cultured with vanadate were
doubly stained . Patterns of staining of cells of types 1 and
2 were subdivided as shown in Fig. 4 to reflect apparent stages
of endocytosis and redistribution from the cell surface to the
juxtanuclear region . At every time point, we found that redis-
tribution of sIg label in individual cells was more advanced
than that of phosphotyrosine label . For example, in the cells
shown in Fig. 3 A, e, sIg was classified as type 2b while PY20
labeling was type 1 or 2a. Since this difference in the staining
patterns was not affected by vanadate, it is not likely to be
owing to dephosphorylation of phosphoproteins during redis-
tribution to thejuxtanuclear region. We conclude that cross-
linked sIg is internalized more rapidly than the bulk of the
sIg-associated, tyrosine phosphorylated proteins . sIg and phos-
photyrosine were colocalized at the cell surface in all cells.
Type 3 cells (Figs. 2 and 3 A, d), in which sIg remained
on the cell surface in patches, also did not redistribute PY20-
stained dots during the observation period . We then deter-
mined how vanadate affected PY20 staining on these cells
(Table 1) . After 1 h of stimulation in the presence of vana-
date, 10% of cells were diffusely positive for PY20 . The
majority (80%) of type 3 cells had varying degrees of diffuse
PY20 staining in addition to the PY20 staining, which was
congruent to the sIg patches. In contrast, only 3% of type
1 and 2 cells showed diffuse staining .
We found that crosslinking of sIg also induces tyrosine
phosphorylation beneath crosslinked sIg receptors in normal
B cells. PY20 labeling was observed with patched or capped
sIgM or sIgG molecules (Fig . 5), but not without stimula-
tion with anti-Ig antibodies (data not shown) . This finding
is consistent with the previous studies (13-15), which showed
that in both normal B cells and B cell lines crosslinking sIg
stimulates phosphorylation of protein tyrosine .
Inhibition ofTyrosine Phosphorylation by Genistein. Genistein,
an inhibitor of PTK (26), did not inhibit PY20 labeling when
added 10 min after anti-human Ig antibodies, but it did block
PY20 labeling when added 10 min before anti-Ig antibodies,
(Fig . 6, A and B) . The percentage of positive cells did not
Figure 3.
	
Double staining for sIg and phosphotyrosine molecules (A)
and for wheat germ agglutinin and phosphotyrosine (B) . (A) Cells were
incubated with FITC-conjugated F(ab')2 fragments of goat anti-human
Ig antibodies, fixed, and stained with PY20 mAb followed by TRITC-
conjugated donkey anti-mouse Ig antibodies. Akatacells were treated with
anti-Ig antibodies for 10 min (a and b) and for 30 min (c, d, and e) . Ramos
cells treated for 30 min (f) . PY20 labeling and sIg overlapped at cell sur-
faces but juxtanuclear accumulation of sIg was not always accompanied
by PY20-labeled proteins (e) . (a, c-f) x900; (b) x1,500. (B) Akata cells
were incubated with anti-IgG for 15 min and fixed. They were then la-
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Figure 4. Comparative redistributions in time of sIg and PY20-labeled
molecules. Akata cells were incubated with FITC-conjugated F(ab')2 frag-
ments of goat anti-human IgG in the presence of 1 mm vanadate, fixed,
and stained as described for Fig. 3. They were examined for sIg (FITC)
(marked S) and for PY20 (TRITC) (marked P) . Cells were classified ac-
cording to the illustrated criteria and the percentages of cells of each type
were determined. Immunofluorescence was scattered on the cell surface
without (type 1) or with a slight concentration (type 2a), or with an ap-
parent concentration (type 2b) ofimmunofluorescence in thejuxtanuclear
region . Immunofluorescence was not observed over the whole cell, but
was concentrated in the juxtanuclear region with (type 2c) or without
(type 2d) cytoplasmic vesicles. Type 3 cells (Fig. 2 and 3 A, rl) were excluded.
Table 1. Vanadate Induces Diffuse PY20 Staining in Type 3
Ahata Cells
Akata cells were incubated for 1 h with FITC-conjugated anti-Ig anti-
bodies and sodium vanadate (1 .0 mM). Cells were fixed and stained with
PY20 mAb followed by TRITC-conjugated donkey anti-mouse antibod-
ies . 1,000 cells were classified as described in Fig . 2 . Diffuse PY20 stain-
ing in type 3 cells was significantly more frequent than that in type 1
or 2 cells (p < 0.001, as determined by the X2 test) .
decrease at 10 and 30 hg/ml, but decreased markedly at 100
leg/ml . The intensity of immunofluorescence ofthe positive
cells did not change at 10 Ag/ml, but was moderately re-
duced at 30 lAg/ml (data not shown) . The DMSO that was
used to dissolve the genistein had no effect by itself. In doubly
labeled cells, which were incubated with FITC-conjugated
anti-Ig antibodies in the presence of genistein (100 Ag/ml),
sIg molecules patched on the cell surface in the absence of
any PY20-stained dots (Fig. 6 B) . We conclude that sIg patch
beled with PY20 mAb followed by FITC-conjugated goat anti-mouse Ig
antibodies (a) and TRITC-conjugated wheat germ agglutinin (b) . The
PY20-labeled proteins accumulated in the juxtanuclear region which was
also stained by wheat germ agglutinin (x500) .










Type 1, 2 79 .7 77 .3 2.4
Type 3 10.0 2.0 8 .0
Figure 5 .
	
Double staining for sIg and phosphotyrosine molecules in
normal B cells . Blymphocytes from peripheral blood were incubated with
FITC-conjugated F(ab')2 fragments of goat anti-human IgM or IgG an-
tibodies and stained for phosphotyrosine as described for Fig. 3: sIg labeling
(B, E, and H), phosphotyrosine labeling (C, F, and Il ; and the corre-
sponding phase contrast pictures (A, D, and G). Patching of slg (B) after
5 min ofincubation with anti-human IgM antibodies accompanies phos-
photyrosine staining (C) . Capping after 15 min of incubation with
anti-human IgM (E) or IgG (H) antibodies also accompanies coordinate
redistribution of phosphotyrosine labeling (For I, respectively) (x950) .
formation was independent of tyrosine phosphorylation in
these cells . However, we did not see internalization of sIg
label in the presence of genistein. When genistein-treated,
anti-IgG crosslinked cells were washed after 20 min and
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Figure 6. Genistein blocks tyrosine phosphorylation. (A) Akata cells
were treated with genistein (10, 30, or 100 ug/ml) for 10 min, stimulated
with anti-human Ig antibodies for 10 min, and stained with PY20 mAb
as described for Fig . 1. (B) Double immunofluorescence labeling for sIg
and phosphotyrosine molecules after incubation with genistein (100 Itg/ml) .
Patching of sIg (a) was not accompanied by phosphotyrosine staining (b)
(x600) .
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Figure 7. PY20 mAb staining of cells cultured with polyacrylamide beads
bearing anti-Ig antibodies. Akata cells (A, B, and C), and Ramos cells
(D, E, and F), andperipheral blood B cells (G, H, and 1) were stimulated
with beads for 30min and stained as described for Fig. 3 . Phosphotyrosine
was localized to the cell membrane attached to beads (C, F, and I) . Phase
contrast micrographs (A, D, and G), and staining with FITC-conjugated
donkey anti-rabbit Ig antibodies (B, E, and H) of the same fields . Phos-
photyrosine appeared where the cells were bound to beads (x700) .
photyrosine formation were foundjust after genistein removal
(data not shown) .
Tyrosine Phosphorylation ofCells Stimulated by Anti-Ig Bound
to Polyacrylamide Beads. To examine further the spatial rela-
Figure 8 . Phosphotyrosine staining of cells with crosslinked Con A
receptors. Peripheral blood B cells (A, B, and C) or Akata cells (D and
E) were incubated with TR.ITC-conjugated Con A (30 jig/ml) for 30
min at 37 °C, fixed, and stained for phosphotyrosine as described Fig. 3 .
Tyrosine phosphorylation (C and E) is not observed beneath patched or
capped Con A receptors (B and D, respectively) . (A) the phase contrast
micrograph of the same cell in B and C. (A, B, and C) x 1,200 ; (D and
E) x 750 .
tionship between sIg and phosphotyrosine-containing mole-
cules, anti-Ig bound to polyacrylamide beads was used to
stimulate Akata, Ramos, and peripheral blood B cells . PY20
mAb labeling was observed only in the cellular regions ad-
hering to the beads (Fig . 7) . No phosphotyrosine im-
munofluorescence was seen in the rest of the cytoplasm or
the nucleus. Most beads remained on the cell surface even
after 18 h in culture, when PY20 labeling was still observed .
Con A Does Not Induce Tyrosine Phosphorylation beneath Cross-
linked Receptors. To examine whether tyrosine phosphory-
lation beneath crosslinked sIg is a general phenomenon that
accompanies any ligand-induced surface receptor-cytoskeleton
interaction, we examined the distribution of phosphotyro-
sine during patching and capping of Con A surface glyco-
protein receptors (Fig. 8) . Incubation of peripheral blood B
cells or Akata cells with Con A at 37°C induced patching,
capping, and internalization of Con A receptors . In addition,
Con A induced marked agglutination of Akata cells and ac-
cumulated at their contact area . Phosphotyrosine formation
could not be detected in Con A-treated cells at any time during
the observation period of 120 min, indicating that tyrosine
phosphorylation beneath crosslinked receptors is specifically
associated with sIg crosslinking .
Discussion
We have analyzed tyrosine phosphorylation induced by
crosslinking sIg in B cells by immunofluorescent staining with
an antiphosphotyrosine mAb . The staining was specific for
phosphotyrosine (Fig. 1 D) . Induction of the phosphoryla-
tion was inhibited in cells treated with the tyrosine kinase
inhibitor, genistein (Fig. 6) . Tyrosine phosphorylation was
induced rapidly, and the phosphorylated substrates patched
and were redistributed in association with the crosslinked sIg.
Tyrosine phosphorylation was observed in both normal B cells
and neoplastic B cell lines and in both sIgM+ cells and
sIgG' cells, indicating that colocalization of anti-Ig-induced
tyrosine phosphorylated proteins with sIg is a general pheno-
menon that accompanies the crosslinking of sIg molecules .
Rapid protein tyrosine phosphorylation of a number of
substrates in sIg-crosslinked, human and murine B cells has
been demonstrated by others by immunoblotting of SDS-
PAGE-separated proteins with antiphosphotyrosine antibodies
or by polyacrylamide gel electrophoresis of "P-labeled mol-
ecules isolated on antiphosphotyrosine Sepharose (13-15) . The
phosphorylated proteins were found in the cytoplasm and
membrane proteins that were solubilized with Triton X-100,
and in the Triton X-100-insoluble fraction of cells (13) . We
do not know exactly which protein substrates for PTK were
principally detected in our immunofluorescence assay. While
several proteins were reported in immunoblots to be phos-
phorylated on tyrosine residues without anti-Ig stimulation
(13-15), phosphorylation was detected by immunofluores-
cence only in stimulated cells (Fig . 1 F) . Thus, not all PTK
substrates may be detected by immunofluorescent staining .
After incubation with vanadate, a PTPase inhibitor, some cells
diffusely stained by PY20 mAb appeared, presumably due
to the accumulation ofphosphotyrosyl residues. These diffusely
distributed, phosphorylated substrates were not lost during
fixation, but smaller amounts in a diffuse distribution might
have eluded detection by immunofluorescent staining. Alter-
natively, the presence ofvanadate in the cell fractionation proce-
dures used by others may have led to the accumulation of
phosphotyrosine above the levels foundin unmanipulated cells .
In contrast, sIg crosslinking induced PY20-labeled dots that
were redistributed in a manner similar to sIg receptors. There-
fore, the major substrates detected in this study were, like
crosslinked sIg, associated physically with the cytoskeletal com-
ponents .
In our work, tyrosine phosphorylation was demonstrated
initially in regions submembranal to crosslinked sIg. Upon
crosslinking of sIg molecules by soluble anti-Ig antibodies,
the tyrosine phosphorylated molecules appeared rapidly as
numerous tiny dots and then redistributed to thejuxtanuclear
region in the majority of the Akata cells . Double staining
analyses demonstrated that the sIg and tyrosine phosphorylated
molecules were closely associated at the cell surface (Fig . 3),
but sIg appeared to move more rapidly to the juxtanuclear
region than did phosphorylated substrates (Figs . 3 A, e, and
4) . When cells were stimulated by anti-Ig antibodies bound
to beads, the tyrosine phosphorylated substrates appeared only
near the cell surface beneath the beads where they remained
for hours . These results are consistent with the view that
activation of PTK takes place where sIg receptors are cross-
linked and may reflect a role of PTK as a transducer in the
signaling pathway.
Since tyrosine phosphorylation was detected at the sites
where sIg formed patches or caps, some PTK substrates
colocalize with the sIg . Calmodulin and several cytoskeletal
proteins such as actin, myosin, vimentin, a-actinin, and fo-
drin accumulate beneath sIg patches or caps (reviewed in ref-
erence 27) . Some of these molecules could be components
of a "signal transduction complex" beneath the sIg patches,
while others may function in patching and endocytosis of
antigen . Whether such cytoskeletal proteins were actually
substrates for PTK in our experiments is not clear . In Rous
sarcoma virus-transformed chick cells, vinculin, a cytoskeletal
protein localized in adhesion plaques, is a substrate for
p60°'SI1 PTK (28) . In cell-free systems, several cytoskeletal
proteins are phosphorylated on tyrosine residues by receptor
tyrosine kinases, while none were reported to be tyrosine phos-
phorylated in intact cell systems (29) . CD19, which co-caps
with sIg (30), forms a complex with CD21 (31) . Both have
tyrosine residues in their cytoplasmic domains and are thus
candidates for PTK substrates. Anti-Ig also induces redistri-
bution and colocalization of p21i'1 in B lymphocytes (32) .
A GTP-binding protein has been implicated in coupling of
sIg to inositol phospholipid hydrolysis (7-10), but as yet, no
role for p21- in signal transduction or capping has been es-
tablished . Tyrosine phosphorylation is implicated in the acti-
vation of PLC after receptor tyrosine kinase activation
(reviewed in reference 33) . Tyrosine phosphorylation is sug-
gested to be an early, essential step in PLC activation in T
cells (reviewed in reference 34) and B cells (35) . Human B
cells have a 146-kD PLC (36), and some substrates for PTK
in B cells have a similar molecular mass (13, 14) .
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Likely candidates for phosphorylated substrates detected
by immunofluorescence are PTKitself and potential members
of a sIg signal transduction complex. Several PTKs of the
src gene family are expressed as cytoplasmic membrane-
associated proteins in B cells (37, 38). As PTKs are phos-
phorylated on tyrosine in cells (39), one or more could be
detected by immunofluorescent staining, if they coalesce be-
neath sIg patches by physical association with a member of
the sIg signal transfer complex in a manner analogous to the
association of CD4/CD8-p56kk complexes with the antigen
receptor in T cells (40, 41). This is supported by the recent
study (42) that showed that the lyn protein and its kinase
activity could be coimmunoprecipitated with IgM from B
cell lysates . CD4-CD4 crosslinking in T cells induces phos-
phorylation ofthree substrates that are also physically associated
with CD4-p561ck complex as an oligomer (43) . The ~chain
of the TCItCD3 complex is phosphorylated on tyrosine upon
activation (44), and the y, S, and e chains of the CD3 com-
plex are tyrosine phosphorylated by the CD4/CD8-p561ck
complex in an in vitro assay (41) . Similarly, components of
the sIg receptor complex could be immunoprecipitated by
antiphosphotyrosine antibodies in B cells after GTP-binding
protein stimulation (12) . It is possible that these B cell ele-
ments were also seen by our immunofluorescence assay.
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